|
|
||||||||
1 Department of Life Science, Graduate School of Biostudies;
2
Experimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University, 53 Kawara-cho, Shogoin, Sakyo-ku, Kyoto Kyoto 606-8507, Japan
3
Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan
4
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Block MD9, 2 Medical Drive, Singapore 117597, Singapore
5
Department of Environmental and Preventive Medicine, Shimane University School of Medicine, 89-1 Enya-cho, Izumo Shimane 693-8501, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The remaining approximately 10% of the cancer cells are telomerase negative, but still maintain their telomeres by the alternative lengthening of telomeres (ALT) pathway (Shay & Bacchetti 1997). Previous studies have identified ALT-associated PML bodies (APBs) in various human ALT cell lines (Yeager et al. 1999) that contain telomeric DNA, telomere-specific binding proteins TRF1, TRF2 and Rif2, DNA repair proteins including MRE11, RAD50, NBS1, RAD51, RAD51D, RAD52, ERCC1, XPF, RAD1, RAD9, RAD17, HUS1 and phospho-H2AX (
H2AX), the replication protein RP-A, and the RecQ helicases BLM and WRN (Yeager et al. 1999; Henson et al. 2002; Nabetani et al. 2004). Furthermore, many ALT cells exhibit a high rate of postreplicative exchange between telomeres of sister chromatids, T-SCE (Wu et al. 2000; Bailey et al. 2004; Bechter et al. 2004; Londono-Vallejo et al. 2004). These data suggest that the DNA double-strand break (DSB) repair machinery, especially for homologous recombination (HR), contributes to the ALT mechanism (Dunham et al. 2000; Reddel 2003). Reporter assays using a neo gene stably integrated in the telomeric regions of ALT cells also suggested that telomeres are lengthened by recombination (Dunham et al. 2000). Taking these observations into account, break-induced replication (BIR) and recombination-based models of ALT have been proposed in which polymerization-mediated extension of one telomere uses the DNA of a second telomere as a template (Reddel et al. 1997; Bosco & Haber 1998; Teng et al. 2000; Reddel 2003; McEachern & Haber 2006).
For the molecular basis of ALT, the MRE11/RAD50/NBS1 complex has been shown to be important (Jiang et al. 2005). Furthermore, WRN helicase represses T-SCEs in ALT type cells (Laud et al. 2005). Other proteins involved in DNA recombination and repair including the Ku/DNA-PKcs complex components (Bailey et al. 1999; Samper et al. 2000; Goytisolo et al. 2001), BLM (Stavropoulos et al. 2002), RAD51D (Tarsounas et al. 2004), and Rad54 (Jaco et al. 2003), are also reported to be important for telomere maintenance, but their contributions to the ALT pathway have not been fully examined.
To further elucidate molecular mechanisms underlying ALT, we here inactivated Rad54 in the mouse ALT embryonic stem (ES) cells. Rad54 is a double-stranded DNA-dependent ATPase and an important accessory factor for Rad51, a key molecule in HR (Tan et al. 2003). Although Rad54-deficient mice are viable and fertile, they are sensitive to ionizing radiation and some DNA-damaging agents, and show reduced HR efficiency as measured by gene targeting and aberrant DSB repair (Essers et al. 1997; Dronkert et al. 2000). Rad54-deficiency also induces telomere shortening and increased frequency of end-to-end telomere fusions in mice, suggesting important roles of Rad54 in telomere length regulation and telomere capping (Jaco et al. 2003). Furthermore, genetic studies of the yeast survivors from the telomerase inactivation demonstrated that RAD54 is involved in the RAD51-dependent telomere lengthening pathway (Chen et al. 2001). Therefore, we decided to inactivate Rad54 in mouse ALT ES cells and examine the impact of Rad54-deficiency on telomere homeostasis and ALT-associated phenotypes.
| Results |
|---|
|
|
|---|
Two independent mTERC-deficient survivor ES cell lines were established as previously reported (Niida et al. 1998; Niida et al. 2000). Both survivor lines contain only fused chromosomes (Niida et al. 2000 and Fig. S1), but maintain telomeres in the telomerase-independent fashion. Furthermore, one of the survivors named DKO741ALT showed amplification of the same tandem arrays of telomeric and non-telomeric sequences at most chromosome ends, suggesting cis/trans recombination/amplification as one of the mechanisms for ALT (Niida et al. 2000). To inactivate Rad54, we deleted exon IV of the Rad54 gene, resulting in elimination of approximately 90% of the protein, as used earlier for Rad54 disruption (Essers et al. 1997). However, if inactivation of Rad54 were to immediately induce a growth defect of DKO741ALT ES cells due to severe telomere dysfunction, we would not expect to obtain Rad54-deficient ALT ES cells by simple Rad54 targeting. To avoid this possibility, we introduced a conditional KO allele by inserting loxP sites flanking exon IV of the Rad54 gene. As illustrated in Fig. 1A, we sequentially replaced the endogenous Rad54 allele with the conditional KO vector and finally established conditional Rad54 KO (Rad54flox/floxneo) DKO741ALT cell. Western blot analysis revealed that Rad54 expression was detected in this conditional Rad54 KO ALT ES cell line, D107A9 (Fig. 1D). After infection with adenovirus expressing cre recombinase (Adeno-Cre), exon 4 could be deleted from both Rad54 conditional KO alleles. We treated the Rad54+/flox (D107) and Rad54flox/floxneo (D107A9) ALT ES cell lines with Adeno-Cre and analyzed the Rad54 expression 3 days postinfection. As clearly shown in Fig. 1D, Rad54 was mostly absent in the Adeno-Cre-treated D107A9 ALT ES cells (/) but not in the Rad54+/flox ALT ES cells (+/). Southern blot analysis further confirmed deletion of Rad54 exon IV by the Adeno-Cre treatment (Fig. 1C). Genotypes of the cells used in this study are summarized in Fig. 1B.
|
Rad54-deficient DKO741ALT ES cells are sensitive to ionizing radiation, but do not show any growth defect
It has been reported that mouse Rad54-deficient cells are sensitive to ionizing irradiation and various other DNA-damaging agents (Essers et al. 1997). To examine whether inactivation of the Rad54 gene also induces DNA DSB repair defects in mouse ALT ES cells, we compared radiosensitivity between Rad54flox/floxneo ALT ES (D107A9) and Rad54/ ALT ES (D107A9cre) cells. As shown in Fig. 2A, D107A9cre cells were found to be more sensitive to
-irradiation than D107A9 cells or their parental cell, DKO741ALT.
|
Telomere dynamics in the Rad54-deficient DKO741ALT ES cells
To examine the telomere dynamics in Rad54-deficient DKO741ALT ES cells, we performed two different experiments. Because DKO741ALT cells amplify tandem arrays of telomeric and nontelomeric sequences at most chromosome ends and regular four- or five-base restriction enzymes digest their telomeric DNA arrays (nontelomeric sequences) (Niida et al. 2000), we could not apply standard telomeric DNA Southern blot analysis. Therefore, we performed slot-blot DNA hybridization to measure the telomeric DNA contents. As shown in Fig. 3A, the ALT-inactive parental mTERC-deficient ES cells demonstrated progressive reduction in telomeric DNA contents. On the other hand, we did not observe any progressive telomeric DNA loss in D107A9 ALT ES cells and their telomeric repeats were heterogeneous in nature at different PDLs, which is a typical phenotype for most human ALT cells. Furthermore, telomeres of the Rad54-deficient D107A9Cre also behaved as D107A9 (Fig. 3A, right panel). Therefore, these data strongly suggest that Rad54 is dispensable for the ALT pathway activated in mTERC-deficient survivor cells.
|
Lack of changes of APB-associated
H2AX in Rad54-deficient DKO741ALT ES cells
Although Rad54 could be shown to be dispensable for the ALT pathway of the mTERC-deficient survivor ES cells, we further determined the impact of Rad54 deficiency on other ALT-associated phenotypes. Because
H2AX is known to accumulate in the APBs of various human ALT cells, we analyzed telomere accumulation of
H2AX in DKO741ALT ES cells. As seen in Fig. 4 and summarized in Table 1,
H2AX positive cells were increased in DKO741ALT (64.8%) and D107A9 (67.0%) as compared with the wild-type ES cells (25.0%). Furthermore, most
H2AX positive survivor ES cells possessed telomere (TRF1)-associated
H2AX foci (53.6 and 64.5% for DKO741ALT and D107A9 comparing to 1.9% for E14). Therefore, telomere-associating
H2AX was also shown to be linked with the mouse ALT cells. Further analysis of telomere-associated
H2AX foci in D107A9Cre cells demonstrated the percentage of positive cells to remain high with no significant decrease (51.8%).
|
|
As described earlier, many ALT cells feature a high rate of postreplicative exchange between telomeres of sister chromatids, T-SCE (Bailey et al. 2004; Bechter et al. 2004; Londono-Vallejo et al. 2004). Therefore, we lastly tested whether mTERC-deficient survivor ES cells had an activated T-SCE pathway. As shown in Fig. 5 (arrows) and summarized in Table 2, T-SCE was greatly increased in DKO741ALT ES cells (1.40 ± 0.11 events per chromosome (epc), mean ± SE) but not in wild-type ES cells (0.0015 ± 0.001 epc). This high rate of T-SCE was not affected by the Rad54 inactivation (1.48 ± 0.10 epc for D107A9Cre). General SCE was also examined for the parental E14, DKO741ALT and D107A9Cre cells (Table 3, top). The general SCE in DKO741ALT was increased about twice (11.6 ± 1.6 events per metaphase (epm)) as compared to E14 (6.56 ± 1.9 epm), and inactivation of Rad54 did not affect the general SCE rate (11.0 ± 2.1 epm for D107A9Cre). However, as earlier reported for mouse Rad54 deficient ES cells (Dronkert et al. 2000), MMC-stimulated general SCE was still suppressed by the Rad54 inactivation in the DKO741 survivor ES cells (4.57 ± 0.60 epc for DKO741ALT and 1.74 ± 0.30 epc for D107A9Cre) (Table 3, bottom).
|
|
|
| Discussion |
|---|
|
|
|---|
Generalization of our current findings to the mammalian ALT pathway(s)
Because DKO741ALT features amplification of tandem arrays of telomeric and non-telomeric sequences, it tends to be classified type of cell line distinct from the majority of mammalian ALT cell lines that amplify and maintain only telomeric DNA sequences on telomeres. Survivor cells of Saccharomyces cerevisiae from deletion of telomerase genes are also known to maintain their telomere lengths, using a RAD52-dependent HR pathway (Lundblad & Blackburn 1993; McEachern & Blackburn 1995; Teng et al. 2000; Chen et al. 2001). Survivors utilize two types of ALT pathways, I and II. Type I survivors have very short C13A/TG13 tracts but exhibit multiple tandem copies of the subtelomeric Y' element, depending on RAD51, RAD54, RAD57, and Sgs1 genes, whereas type II survivors only amplify C13A/TG13 tracts and have significant telomere lengthening and heterogeneity, depending on RAD50, RAD59 (Chen et al. 2001; Tsai et al. 2006). Based on such a different yeast telomeric DNA amplification phenotype, DKO741ALT seems to be a mammalian type I counterpart. However, these yeast survivors have been functionally characterized and classified so that type I survivors utilize > 100 base pairs of homology sequences of multiple Y' elements for maintaining telomeres by the RAD51-dependent HR pathway and type II survivors use only shorter homology TG13 tracts to elongate telomeres by the RAD50-dependent recombination pathway (Chen et al. 2001; McEachern & Haber 2006). Unlike yeast telomeres, mammalian telomeric DNA consists of highly homologous TTAGGG tracts (> kb). Therefore, based on the nature of the amplified telomeric DNA sequences, not only DKO741ALT but also the majority of human ALT cell lines can be classified as mammalian type I survivors. We also hypothesize that the nontelomeric sequences amplified in DKO741ALT originated from subtelomeric (mixture of telomeric and nontelomeric arrays) regions (Niida et al. 2000). Although the nontelomeric sequences amplified in DKO741ALT have still not been mapped to any mouse chromosomes by a mouse full-genome database search, this result suggests that they are likely to be located in highly repetitive sequence regions like telomeres. If so, intra- and interchromosomal BIR/recombination between telomeres and subtelomeres could easily amplify nontelomeric sequences and an additional ALT mechanism for DKO741ALT would not be expected. Furthermore, except for the telomeric DNA phenotype, DKO741ALT shows the typically observed phenotypes of human ALT cell lines, including telomere length heterogeneity (Fig. 3B), APB-associated
H2AX, and T-SCE. These phenotypes are also shared by another mTERC-deficient ALT ES cell line, DKO301ALT (Niida et al. 2000 and not shown). Even if such type I/II distinction is not well established in mammals, assuming the previously mentioned hypothesis to be correct, we can apply our conclusions obtained with DKO741ALT to the general case of mammalian ALT cells.
Why is Rad54 dispensable for telomere lengthening in DKO741ALT?
In yeast, Rad54 plays crucial roles in the RAD51-dependent HR pathway and disruption of RAD54 inactivates RAD51-dependent telomere lengthening (Chen et al. 2001). If DKO741ALT is a mammalian type I survivor and the Rad51-pathway is critical for the telomere lengthening, why did Rad54-deficiency not affect telomere maintenance in our DKO741ALT? A number of explanations are possible. (1) As with yeast type I survivors, the Rad51-dependent pathway is crucial for the telomere maintenance of DKO741ALT, but Rad54 is not indispensable. Rad54-deficient cells grow normally (Essers et al. 1997), but Rad51 is essential for cell growth and survival (Lim & Hasty 1996; Tsuzuki et al. 1996; Sonoda et al. 1998). Therefore, even if Rad54 plays some roles in DSB repair and HR, the Rad51-dependent pathway may still function on BIR and recombination and maintain telomere length in its absence. (2) Rad54 paralogs could play important roles in telomere maintenance of DKO741ALT and one example, Rad54B, exists in mammals and is known to partly compensate for Rad54-defective phenotypes in mouse ES cells (Wesoly et al. 2006). However, Rad54B-inactivation phenotypes are much milder than those with Rad54-deficiency and Rad54/Rad54B double deficient mice are still viable and fertile, and double KO ES cells could be shown to grow normally. Therefore, even if Rad54 paralogs play some roles in ALT, Rad54B's contribution may be minimal (so far, only Rad54 and Rad54B are classified as the Rad54 paralogs in mouse). In this context it should be noted that we examined Rad54B expression before and after Rad54 inactivation, but no up-regulation of Rad54B was observed in D107A9Cre (data not shown). (3) The Rad51/Rad54-dependent pathway is dispensable for the telomere maintenance of DKO741ALT but (an)other DSB repair pathway(s) is crucial. Alternatively, multiple pathways including the RAD51-dependent pathway cooperatively elongate telomere length and disruption of a single pathway may not have a clear impact on telomere lengthening. Mammalian telomeres form T-loop structures (Griffith et al. 1999) that may contribute to the reduction of their dependence on the Rad51-dependent pathway for telomere elongation because TRF2 could potentially bypass Rad51-mediated strand-invasion. MMC-stimulated SCE was here found to be sensitive to Rad54 inactivation in DKO741ALT, but T-SCE was not. If TRF2 is also involved in strand-invasion between sister chromatid telomeres, this might explain why T-SCE was resistant to Rad54 deficiency because it is thought to be generated from the resolution of BIR/HR between sister chromatid telomeres.
It is still important to identify molecules that are directly involved in telomeric DNA elongation/amplification in ALT cells. However, studies of the WRN-deficient mouse embryonic fibroblasts clearly showed that inactivation of WRN alone is not sufficient for the activation of ALT (Laud et al. 2005). Thus, it is also important to elucidate how the ALT pathway(s) is normally suppressed or how such suppression might be canceled in ALT cells.
| Experimental procedures |
|---|
|
|
|---|
A BAC (bacterial artificial chromosome) clone containing a region of the Rad54 locus of Mus musculus, RP23319H15 was purchased from the BACPAC Resource Center (BPRC) at Children's Hospital Oakland Research Institute in Oakland, California, in the United States. The clone was modified as previously described (Liu et al. 2003).
Briefly, RP23319H15 was transferred into the bacterial strain, EL350, which expresses cre recombinase on arabinose induction. A loxP site was inserted approximately 200 bp upstream of exon IV, and a FRT (Flp recognition target)-pgk neo-FRT-loxP cassette approximately 200 bp downstream of exon IV. The same region as previously reported for a Rad54 targeting strategy (Essers et al. 1997) was retrieved from the modified BAC, using a linearized plasmid, arms homologous to the approximately 7 kb upstream of exon IV and approximately 2 kb downstream of the FRT-pgk neo-FRT-loxP cassette, and a diphtheria toxin A (DTA) gene. The targeting vector was digested with PmeI for linearization, and electroporated.
Generation of knockout ES cells
mTERC (mouse Telomerase RNA component) knockout ES cells and the survivor cell line, DKO741ALT were as previously described (Niida et al. 1998; Niida et al. 2000).
Ten micrograms of linearized Rad54 conditional targeting vector were electroporated into 107 mouse ALT cells at 300 V, 75uF with a Gene Pulsar II (BIORAD). The neomycin-resistance gene (neo) was used as a positive selection marker and DTA as a negative selection marker. G418-positive clones were screened and those that were PCR positive were checked by Southern blotting. Of 385 G418-resistant clones screened, four had undergone homologous recombination correctly. pCAGGS-FLPe-IRES-puro was a gift from Dr H. Hamada, Osaka University. To generate the conditional allele, the neo gene was deleted by transfecting the targeted cell with the Flp expression vector and selection with 1.5 µg/mL puromycin. Heterozygous targeted cells were retargeted in the same way as described previously. After infection with Adeno-cre, expression of the Rad54 protein in the established ES cells was monitored by Western blotting using an anti-hRad54 antibody generated against the N-terminus of human Rad54 (Sc-5849, Santacruz), which cross-reacts with mouse Rad54.
Immunofluorescence
Cytospun cells were fixed onto slides with 4% paraformaldehyde for 20 min, permeabilized with 0.1% Nonidet P-40 (NP-40) for 20 min, and incubated with blocking solution (4% bovine serum albumin, 0.1% NP-40 in phosphate buffered saline (PBS)) at 37 °C for 45 min. Incubation was with rabbit anti-mTRF1 Ab (Iwano et al. 2004) and mouse anti-
H2AX (UPSTATE) diluted to 1 : 200 at 37 °C for 60 min. An anti-mouse IgG conjugated with Zenon Alexa 568 Fluor (Molecular Probes) was used for detection of
H2AX, and an anti-rabbit IgG conjugated with Zenon Alexa 488 Fluor (Molecular Probes) for mTRF1. The slides were examined under a fluorescence microscope and analyzed with AxioVision software (Zeiss).
Cell survival assays
The sensitivity of the cells to increasing doses of ionizing radiation was determined by measuring their colony-forming ability. The cells were trypsinized and counted. Various cell dilutions were aliquoted onto gelatinized six-well plates, and after 1224 h, the cells were irradiated. Cells were grown for 710 days and the number of colonies formed were scored. The measurements were performed in triplicate.
Sister chromatid exchange (SCE) assay
SCE assays were performed as previously described (Sonoda et al. 1999). Briefly, cells grown to approximately 50% confluence were incubated for 48 h (two cell cycles) with 20 mM 5-bromo-2'-deoxyuridine (BrdU) (Sigma) and then treated with 0.1 µg/mL colcemid for 2 h. After harvesting with trypsin, they were swollen for 20 min in 75 mM KCl and fixed for 30 min in methanol: acetic acid (3 : 1). The cells were then dropped onto moist prewashed (with 50% EtOH) glass slides, allowed to dry on a 42 °C hot plate and stained with 10 µg/mL Hoechst 33258 in Phosphate buffer (pH 6.8) for 20 min at 25 °C. The slides were then exposed to UV light for 1 h, using Stratalinker (1800) (Stratagene), washed with 2 x SSC (0.3 M NaCl, 0.03 M sodium citrate) at 62 °C, stained with 3% Giemsa for 50 min and finally air-dried and mounted with glass cover slips in Enteran neu (Merck, Darmstadt, Germany).
For mitomycin C (MMC)-induced SCE, MMC was added to the culture media at a final concentration of 0.1 µg/mL for 16 h prior to harvesting. Slides were analyzed with a bright-field microscope equipped with a 100 x objective.
Chromosome orientation fluorescence in situ hybridization (CO-FISH)
CO-FISH has been previously described in detail (Bailey et al. 2001). Briefly, confluent cultures were subcultured in a medium containing 20 µM BrdU and incubated at 37 °C for 24 h (one cell cycle). Colcemid (0.2 µg/mL) was added during the last 2 h. Cells were trypsinized and suspended in 0.9% citrate buffer at 37 °C for 25 min before fixing in 3 : 1 methanol : acetic acid. Fixed cells were dropped onto wet glass slides, washed with PBS once, treated with 0.5 µg/mL RNase A for 10 min at 37 °C, stained with 0.5 µg/mL Hoechst 33258 (Sigma) in 2 x SSC for 15 min at room temperature and then exposed to 365 nm UV light (Stratalinker 1800) for 30 min. Enzymatic digestion of the BrdU-substituted DNA strands with 3 units/mL of Exonuclease III (Takara) in buffer supplied by the manufacturer (50 mM Tris-Cl, 5 mM MgCl2, and 5 mM dithiothreitol, pH 8.0) was allowed to proceed for 10 min at room temperature. The probe for telomeric DNA was Cy3-labeled (CCCTAA)3 peptide nucleic acid (PNA). Following dehydration through an ethanol series (70, 85, 100%), a hybridization mixture containing 0.5 µg/mL probe PNA in 70% formamide was applied. Following 2 h hybridization in a moist chamber at room temperature, the slides were washed once for 15 min each in wash solution I (70% formamide, 0.1% BSA, 10 mM Tris-Cl-pH 7.5) and then washed 3 times for 5 min with 0.05% Tween-20 in Tris buffered saline. After a second dehydration through an ethanol series (70, 85, 100%), slides were mounted in a Vectashield containing 0.2 µg/mL 40,6-diamidino-2-phenylindole (DAPI) to counterstain chromosomal DNA, examined under a fluorescence microscope, and analyzed with AxioVision software (Zeiss).
Quantification of amounts of telomere repeat sequences (slot-blot DNA hybridization)
Genomic DNA (0.1, 0.3 and 0.5 µg) was loaded onto a 0.8% agarose gel in 1 x TAE and electrophoresed at 100 V for 15 min. The gel was stained with 0.01 µg/mL ethidium bromide and values for fluorescent intensity of each band were acquired by Fluor-S (Bio-Rad). Gels were dried at 70 °C for 40 min, denatured in a 1.5 M NaCl, 0.5 M NaOH solution for 20 min, neutralized in a 1.5 M NaCl, 0.5 M Tris-HCl pH 8.0 buffer for 15 min, and probed with 32P-labeled (C3TA2)4 telomeric DNA oligonucleotides in 5 x SSC, 5 x Denhardt's solution at 37 °C overnight. Following high stringency washes in 0.1 x SSC at room temperature for 1 h, autoradiography was performed and the radioactivity of each band was measured using BAS 5000 (Fuji Film).
Quantative fluorescence in situ hybridization
Cells were harvested after colcemid treatment (0.1 µg/mL) for 2 h, washed with PBS, swollen for 25 min in 0.03 M sodium citrate buffer and fixed in methanol: acetic acid (3 : 1). Cell suspensions were then placed on wet, clean slides and dried overnight. FISH with Cy3-labeled (C3TA2)3 peptide nucleic acid was performed as described earlier (Zijlmans et al. 1997; Hande et al. 1999) and metaphase spreads were visualized using a Zeiss Axioplan 2 imaging fluorescence microscope equipped with a CCD camera. Images were captured using ISIS imaging software (Metasystems, Germany) and telomere fluorescence intensities were measured using ISIS telomere software (Metasystems, Germany).
| Acknowledgements |
|---|
| Footnotes |
|---|
* Correspondence: E-mail: yshinkai{at}virus.kyoto-u.ac.jp
| References |
|---|
|
|
|---|
Bailey, S.M., Cornforth, M.N., Kurimasa, A., Chen, D.J. & Goodwin, E.H. (2001) Strand-specific postreplicative processing of mammalian telomeres. Science 293, 24622465.
Bailey, S.M., Goodwin, E.H. & Cornforth, M.N. (2004) Strand-specific fluorescence in situ hybridization: the CO-FISH family. Cytogenet. Genome Res. 107, 1417.[CrossRef][Medline]
Bechter, O.E., Shay, J.W. & Wright, W.E. (2004) The frequency of homologous recombination in human ALT cells. Cell Cycle 3, 547549.[Medline]
Bosco, G. & Haber, J.E. (1998) Chromosome break-induced DNA replication leads to nonreciprocal translocations and telomere capture. Genetics 150, 10371047.
Cech, T.R. (2004) Beginning to understand the end of the chromosome. Cell 116, 273279.[CrossRef][Medline]
Chen, Q., Ijpma, A. & Greider, C.W. (2001) Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol. Cell. Biol. 21, 18191827.
Dronkert, M.L., Beverloo, H.B., Johnson, R.D., Hoeijmakers, J.H., Jasin, M. & Kanaar, R. (2000) Mouse RAD54 affects DNA double-strand break repair and sister chromatid exchange. Mol. Cell. Biol. 20, 31473156.
Dunham, M.A., Neumann, A.A., Fasching, C.L. & Reddel, R.R. (2000) Telomere maintenance by recombination in human cells. Nature Genet. 26, 447450.[CrossRef][Medline]
Essers, J., Hendriks, R.W., Swagemakers, S.M., Troelstra, C., de Wit, J., Bootsma, D., Hoeijmakers, J.H. & Kanaar, R. (1997) Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89, 195204.[CrossRef][Medline]
Goytisolo, F.A., Samper, E., Edmonson, S., Taccioli, G.E. & Blasco, M.A. (2001) The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21, 36423651.
Griffith, J.D., Comeau, L., Rosenfield, S., Stansel, R.M., Bianchi, A., Moss, H. & de Lange, T. (1999) Mammalian telomeres end in a large duplex loop. Cell 97, 503514.[CrossRef][Medline]
Hande, M.P., Samper, E., Lansdorp, P. & Blasco, M.A. (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144, 589601.
Henson, J.D., Neumann, A.A., Yeager, T.R. & Reddel, R.R. (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598610.[CrossRef][Medline]
Iwano, T., Tachibana, M., Reth, M. & Shinkai, Y. (2004) Importance of TRF1 for functional telomere structure. J. Biol. Chem. 279, 14421448.
Jaco, I., Munoz, P., Goytisolo, F., Wesoly, J., Bailey, S., Taccioli, G. & Blasco, M.A. (2003) Role of mammalian Rad54 in telomere length maintenance. Mol. Cell. Biol. 23, 55725580.
Jiang, W.Q., Zhong, Z.H., Henson, J.D., Neumann, A.A., Chang, A.C. & Reddel, R.R. (2005) Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol. Cell. Biol. 25, 27082721.
de Lange, T. (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 21002110.
Laud, P.R., Multani, A.S., Bailey, S.M., Wu, L., Ma, J., Kingsley, C., Lebel, M., Pathak, S., DePinho, R.A. & Chang, S. (2005) Elevated telomeretelomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 19, 25602570.
Lim, D.S. & Hasty, P. (1996) A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16, 71337143.[Abstract]
Liu, P., Jenkins, N.A. & Copeland, N.G. (2003) A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 13, 476484.
Londono-Vallejo, J.A., Der-Sarkissian, H., Cazes, L., Bacchetti, S. & Reddel, R.R. (2004) Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res. 64, 23242327.
Lundblad, V. & Blackburn, E.H. (1993) An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 73, 347360.[CrossRef][Medline]
McEachern, M.J. & Blackburn, E.H. (1995) Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376, 403409.[CrossRef][Medline]
McEachern, M.J. & Haber, J.E. (2006) Break-induced replication and recombinational telomere elongation in yeast. Annu. Rev. Biochem. 75, 111135.[CrossRef][Medline]
Nabetani, A., Yokoyama, O. & Ishikawa, F. (2004) Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body. J. Biol. Chem. 279, 2584925857.
Niida, H., Matsumoto, T., Satoh, H., Shiwa, M., Tokutake, Y., Furuichi, Y. & Shinkai, Y. (1998) Severe growth defect in mouse cells lacking the telomerase RNA component. Nat. Genet. 19, 203206.[CrossRef][Medline]
Niida, H., Shinkai, Y., Hande, M.P., Matsumoto, T., Takehara, S., Tachibana, M., Oshimura, M., Lansdorp, P.M. & Furuichi, Y. (2000) Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol. Cell. Biol. 20, 41154127.
Reddel, R.R. (2003) Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett. 194, 155162.[CrossRef][Medline]
Reddel, R.R., Bryan, T.M. & Murnane, J.P. (1997) Immortalized cells with no detectable telomerase activity. A review. Biochemistry (Mosc) 62, 12541262.[Medline]
Samper, E., Goytisolo, F.A., Slijepcevic, P., van Buul, P.P. & Blasco, M.A. (2000) Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1, 244252.[CrossRef][Medline]
Shay, J.W. & Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787791.[CrossRef][Medline]
Sonoda, E., Sasaki, M.S., Buerstedde, J.M., Bezzubova, O., Shinohara, A., Ogawa, H., Takata, M., Yamaguchi-Iwai, Y. & Takeda, S. (1998) Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17, 598608.[CrossRef][Medline]
Sonoda, E., Sasaki, M.S., Morrison, C., Yamaguchi-Iwai, Y., Takata, M. & Takeda, S. (1999) Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol. Cell. Biol. 19, 51665169.
Stavropoulos, D.J., Bradshaw, P.S., Li, X., Pasic, I., Truong, K., Ikura, M., Ungrin, M. & Meyn, M.S. (2002) The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet. 11, 31353144.
Tan, T.L., Kanaar, R. & Wyman, C. (2003) Rad54, a Jack of all trades in homologous recombination. DNA Repair (Amst) 2, 787794.[CrossRef][Medline]
Tarsounas, M., Munoz, P., Claas, A., Smiraldo, P.G., Pittman, D.L., Blasco, M.A. & West, S.C. (2004) Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117, 337347.[CrossRef][Medline]
Teng, S.C., Chang, J., McCowan, B. & Zakian, V.A. (2000) Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol. Cell 6, 947952.[CrossRef][Medline]
Tsai, H.J., Huang, W.H., Li, T.K., Tsai, Y.L., Wu, K.J., Tseng, S.F. & Teng, S.C. (2006) Involvement of topoisomerase III in telomere-telomere recombination. J. Biol. Chem. 281, 1371713723.
Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y. & Morita, T. (1996) Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93, 62366240.
Wesoly, J., Agarwal, S., Sigurdsson, S., et al. (2006) Differential contributions of mammalian Rad54 paralogs to recombination, DNA damage repair, and meiosis. Mol. Cell. Biol. 26, 976989.
Wu, G., Lee, W.H. & Chen, P.L. (2000) NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275, 3061830622.
Yeager, T.R., Neumann, A.A., Englezou, A., Huschtscha, L.I., Noble, J.R. & Reddel, R.R. (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 41754179.
Zijlmans, J.M., Martens, U.M., Poon, S.S., Raap, A.K., Tanke, H.J., Ward, R.K. & Lansdorp, P.M. (1997) Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc. Natl. Acad. Sci. USA 94, 74237428.
Received: 6 June 2006
Accepted: 19 August 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |